TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Efficacy of 67Cu-SAR-BBN in terms of radiographic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of dose limiting toxicities of 67Cu-SAR-BBN
Endpoint domain: Adverse events/effects
Primary endpoint: Pediatric KPR knowledge level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric KPR team attitude level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pediatric KPR team performance level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of fluorescence signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Turkish version of the scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Peak serum drug concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistent opioid use after 90 days
Endpoint domain: Adverse events/effects
Primary endpoint: Persistent pain after 90 days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in lung capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of participants with laryngeal web formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Access site complication
Endpoint domain: Adverse events/effects
Primary endpoint: Success rate of PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Upper extremities performance with 9 hole peg test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper extremities performance with Minnesota Manual Dexterity Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive Status with Montreal Cognitive Assessment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Trunk Functions with Trunk Impairment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endometriosis fertility index (EFI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: The Cox Menstrual Symptom Scale (CMSS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of thyroid disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: One year transplant free survival
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of clinically significant CMV infection
Endpoint domain: Adverse events/effects
Primary endpoint: Change in autobiographical memory integration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total Sedentary Behavior Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinicians' understanding of patient's clinical status before and after sNfL results
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinicians' opinion on how sNfL results could guide clinical practice
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Frequency of unscheduled clinician-ordered sNfL measurements
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: knee functional test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Score at 6 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Score at 12 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Score at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in urinary protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Anti-phospholipase A2 receptor (PLA2R) auto-antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Complete response of PMN
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Small intestine residence/transit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Post-intravitreal injection eye pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best combined complete response (CR) and very good partial response (VGPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of the ME-APDS device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: earlier diagnosis of cardiac amyloidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnostic efficiency of 18F-FAPI PET/MRI imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major complications rates
Endpoint domain: Adverse events/effects
Primary endpoint: Visual Analog Scale (VAS) Improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline Pain Intensity at 10 weeks
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change from Baseline Fatigue at 10 weeks
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Musculoskeletal System Health Questionnaire Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: International Physical Activity Questionnaire (short form)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive Failures Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Jamar hand dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression Anxiety Stress Scale - 21 Short Form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum Standardized Uptake Values (SUVmax) over pituitary tumour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with abnormalities from sports training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of complete remission in lower urinary tract symptoms and hematuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Schirmer's Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active and Passive Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Manual Muscle Test for Ankle Dorsiflexors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: AOFAS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of VTE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in modified RDAI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean concentration of vaccine Serotype specific pneumococcal IgG antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Vaccine Serotype specific pneumococcal IgG antibody concentration ≥ 0.35 μg/ml of proportion of subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Intervention Safety benchmark
Endpoint domain: Adverse events/effects
Primary endpoint: Distinguishing healthy tissue from tumoral tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Swallow risk indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in extracellular volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart rate-corrected QT interval (QTcF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: VO2 expressed in mL/min/kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilation expressed as L/min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Ablation Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of wound closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Parkinson Disease Questionnaire-39 (PDQ-39)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Child PTSD Symptom Scale-Interview Version for DSM-5 (CPSS-5-I)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Growth in first 4 months of life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to weight restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: recurrence rate of heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Visual field differential light sensitivity threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Alcohol Craving
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Neck Pain Rating Scale (NPRS)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Goniometric measurement of neck range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rates to self-testing for HPV
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of positivity of HPV tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Follow-up gynaecological care in women who tested positive
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Diagnostic performance of liver and spleen stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric Rating Scale of Low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of days medication taken/applied
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: The reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: BOLD signal (blood oxygen level-dependent)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms and clinical sign
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gestational Diabetes Mellitus (DM) incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Preliminary antitumor activity: Objective response rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of HFiEF at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of the intervention based on number of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline Gross Motor Function Measure 66
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Manual Ability Classification System
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Muscle Electric Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of Intracranial hemorrhage (ICH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neuropathic pain assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Working Alliance Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attitude Towards Psychiatry-30 Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Long-interval intracortical inhibition (LICI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Negative urgency
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: skeletal muscle mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Preparedness for the Future Question score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Level of progesterone on the day of trigger
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: World Health Organization Quality-of-Life Scale (WHOQOL-BREF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Oswetry Disability Index (ODI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: McGill Pain Questionnaire (MGPQ)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Proportion of participants continuing mobile application use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients who adhere to the fast mimicking diet
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ileostomy stoma output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hip pain and function for 6 months after the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Boston Carpal Tunnel Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Diagnosis of PsA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients with successful PICC placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Character strengths of gratitude, kindness and hope
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Nasal Discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crustations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken to successfully insert the Veress needle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Blood pressure measurement performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean LDL-C change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: spontaneous walking speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in perioperative mortality rates
Endpoint domain: Mortality/survival
Primary endpoint: Chronic Respiratory Diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: perceived influence of PrEP use on the quality of sexual life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area under the concentration-time curve (AUC[0-inf]) following administration of CAB DT after a high fat meal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed concentration (Cmax) following administration of CAB DT after a high fat meal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve (AUC[0-last]) following administration of CAB DT after a high fat meal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate success rate of surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Enamel wear of teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate ratio of colorectal cancer recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: rate of retinal redetachment after silicone oil removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SHAP (without device)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: QuickDASH (without device)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SHAP (with device)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: QuickDASH (with device)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Temporal measurements difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Spatial measurements difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Anterior chamber cell clearing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implant Success and Failure Criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MACE in 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Medical resource utilization and costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Resource utilization outside GOG institutions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean number of hours required to complete forms
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Dynamic changes in serum biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best CRR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival without severe intraventricular hemorrhage
Endpoint domain: Mortality/survival
Primary endpoint: Perinatal composite outcome
Endpoint domain: Mortality/survival
Primary endpoint: Change in Smoke Free Home Rules
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time-Weighted Average Airborne Nicotine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial fine lines and wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Facial skin pigment evenness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: 2-years recurrence rate
Endpoint domain: Mortality/survival
Primary endpoint: Functional brain connectivity changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Protein turnover and net protein gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle strength of the forearm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in risk taking behavior
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of usable and quantifiable results from fundus photography, OCT, and OCTA examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Total Pain Relief (TOTPARmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UG microbiota composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in coaches' self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in 4 cardinal symptoms score (4CSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Visual Analogue Scale (VAS) evaluating global disease severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Patient Global Impression of Change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: General creative thinking
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 180 Day Grade III-IV Acute Graft-Versus-Host Disease (GVHD)-Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Person-years incidence of CIN2+ associated with HPV6/11/16/18
Endpoint domain: Mortality/survival
Primary endpoint: Person-years incidence of CIN2+ associated with HPV31/33/45/52/58/59/68
Endpoint domain: Mortality/survival
Primary endpoint: peri-procedural anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Required scan time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Blood examination rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes of spherical equivalent refraction (SER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glycated hemoglobin change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: DASH SCALE (Disability of arm, shoulder and hand)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Recruitment goal
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 14-Day Recovery Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammasome Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevalence of neonatal seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of subjects infected with SARS-CoV-2
Endpoint domain: Adverse events/effects
Primary endpoint: Death of newborns
Endpoint domain: Mortality/survival
Primary endpoint: number of complete phenotyping clinical
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of complete phenotyping radiological
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of complete phenotyping biological samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes